NCT05028114 - Tricaprilin Liquid Formulation PK Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

March 18, 2022

Study Completion Date

July 19, 2022

Conditions

Alzheimer Disease

Interventions

DRUG

AC-1202

Tricaprilin formulated as AC-1202

DRUG

AC-OLE-01

Tricaprilin Formulation

DRUG

AC-OLE-02

Tricaprilin Formulation

DRUG

AC-OLE-03

Tricaprilin Formulation

DRUG

AC-OLE-04

Tricaprilin Formulation

DRUG

AC-OLE-05

Tricaprilin Formulation

DRUG

AC-OLE-06

Tricaprilin Formulation

DRUG

AC-OLE-07

Tricaprilin Formulation

DRUG

AC-OLE-08

Tricaprilin Formulation

DRUG

AC-OLE-09

Tricaprilin Formulation

DRUG

AC-OLE-010

Tricaprilin Formulation

DRUG

AC-OLE-P

Placebo to tricaprilin formulation

Trial Locations (1)

5000

CMAX, Adelaide